These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25937541)

  • 41. A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report.
    Wu S; Wang J; Jing L; Chen L
    Front Endocrinol (Lausanne); 2020; 11():608966. PubMed ID: 33584541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis.
    Zhang J; Chen Y; Wang J; Xia H; Zheng Y
    Nagoya J Med Sci; 2021 May; 83(2):343-351. PubMed ID: 34239182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liraglutide Improves Estimated Glomerular Filtration Rate Slopes in Patients with Chronic Kidney Disease and Type 2 Diabetes: A 7-Year Retrospective Analysis.
    Osonoi T; Saito M; Osonoi Y; Douguchi S; Ofuchi K; Katoh M
    Diabetes Technol Ther; 2020 Nov; 22(11):828-834. PubMed ID: 32348695
    [No Abstract]   [Full Text] [Related]  

  • 44. Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.
    Dujic T; Causevic A; Bego T; Malenica M; Velija-Asimi Z; Pearson ER; Semiz S
    Diabet Med; 2016 Apr; 33(4):511-4. PubMed ID: 26605869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.
    Crowley MJ; McGuire DK; Alexopoulos AS; Jensen TJ; Rasmussen S; Saevereid HA; Verma S; Buse JB
    Diabetes Care; 2020 Sep; 43(9):e108-e110. PubMed ID: 32647053
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study.
    Dujic T; Zhou K; Tavendale R; Palmer CN; Pearson ER
    Diabetes Care; 2016 Nov; 39(11):1896-1901. PubMed ID: 27493135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus.
    Bytzer P; Talley NJ; Jones MP; Horowitz M
    Aliment Pharmacol Ther; 2001 Jan; 15(1):137-42. PubMed ID: 11136287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center.
    Meyers AG; Hudson J; Cravalho CKL; Matta ST; Villalobos-Perez A; Cogen F; Chung ST
    Pediatr Diabetes; 2021 Mar; 22(2):182-191. PubMed ID: 33179823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter to the Editor: Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease.
    Taneja V
    Hepatology; 2020 Mar; 71(3):1128. PubMed ID: 31610029
    [No Abstract]   [Full Text] [Related]  

  • 50. Liraglutide-related cholelithiasis.
    Korkmaz H; Araz M; Alkan S; Akarsu E
    Aging Clin Exp Res; 2015 Oct; 27(5):751-3. PubMed ID: 25725635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Scientific report: a case of acute pancreatitis due to liraglutide.
    Quesada-Vázquez N
    Rev Esp Enferm Dig; 2019 Apr; 111(4):329-330. PubMed ID: 30561221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ondansetron and metformin-induced gastrointestinal side effects.
    Hoffmann IS; Roa M; Torrico F; Cubeddu LX
    Am J Ther; 2003; 10(6):447-51. PubMed ID: 14624284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is there a link between liraglutide and pancreatitis? A post hoc review of pooled and patient-level data from completed liraglutide type 2 diabetes clinical trials.
    Jensen TM; Saha K; Steinberg WM
    Diabetes Care; 2015 Jun; 38(6):1058-66. PubMed ID: 25504028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is a switch from insulin therapy to liraglutide possible in Japanese type 2 diabetes mellitus patients?
    Kawata T; Kanamori A; Kubota A; Maeda H; Amamiya H; Takai M; Kaneshige H; Minagawa F; Iemitsu K; Kaneshiro M; Ishikawa M; Takeda H; Takuma T; Mokubo A; Machimura H; Obana M; Miyakawa M; Naka Y; Suzuki D; Terauchi Y; Toyoda M; Tanaka Y; Matsuba I
    J Clin Med Res; 2014 Apr; 6(2):138-44. PubMed ID: 24578756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Study on Weight Loss Cause as per the Side Effect of Liraglutide.
    Yu J; Lee J; Lee SH; Cho JH; Kim HS
    Cardiovasc Ther; 2022; 2022():5201684. PubMed ID: 36540096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of liraglutide combined with metformin or acarbose on glucose control in type 2 diabetes mellitus and risk factors of gastrointestinal adverse reactions.
    Ren G; Ma X; Jiao P
    Am J Transl Res; 2022; 14(5):3207-3215. PubMed ID: 35702127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of type 2 diabetes in children: what are the specific considerations?
    Grøndahl MFG; Johannesen J; Kristensen K; Knop FK
    Expert Opin Pharmacother; 2021 Nov; 22(16):2127-2141. PubMed ID: 34420454
    [No Abstract]   [Full Text] [Related]  

  • 58. Intentional overdose of liraglutide in a non-diabetic patient causing severe hypoglycemia.
    Solverson KJ; Lee H; Doig CJ
    CJEM; 2018 Oct; 20(S2):S61-S63. PubMed ID: 29397808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early onset of acute pancreatitis in a patient on low-dose liraglutide.
    Chua MWJ; Ng YK
    Diabetes Metab Syndr; 2021; 15(3):753-755. PubMed ID: 33823330
    [No Abstract]   [Full Text] [Related]  

  • 60. Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects.
    Wang Z; Saha S; Van Horn S; Thomas E; Traini C; Sathe G; Rajpal DK; Brown JR
    Endocrinol Diabetes Metab; 2018 Jan; 1(1):e00009. PubMed ID: 30815546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.